CASTRATION-RESISTANT PROSTATE CANCER: SYSTEMIC THERAPY IN 2012

Castration-resistant prostate cancer: systemic therapy in 2012

Prostate cancer is the most common non-cutaneous neoplasm in the male population worldwide.It is typically diagnosed in its early stages, and the disease exhibits a relatively indolent course in most patients.Despite the curability of localized disease with prostatectomy and radiation therapy, some patients develop metastatic disease and die.Althou

read more

Partnering with pediatric patients and families in high reliability to identify and reduce preventable safety events

Frameworks for designing Gua Sha highly reliable behaviors and tools to reduce preventable harm are the result of the continued effort to improve patient safety in healthcare.Evidence shows that there has been limited research on engaging patients and families in the development of safety and reliability efforts to achieve zero harm.Our aim was Glo

read more


Predicting the Next Eye Pathogen: Analysis of a Novel Adenovirus

ABSTRACT For DNA viruses, genetic recombination, addition, and deletion represent important evolutionary mechanisms.Since these genetic alterations can lead to new, possibly severe pathogens, we applied a systems biology approach to study the pathogenicity of a novel human adenovirus with a naturally occurring deletion of the canonical penton base

read more